Summit Securities Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Summit Securities Group's CELG Position: Q4 2019 in Review
Summit Securities Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 32,949 shares — an estimated $3.27M sold.
Summit Securities Group first reported a position in CELG in Q2 2016 and held it in 4 quarters. The position peaked at $3.27M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Summit Securities Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Summit Securities Group sold 32,949 Celgene Corp shares in Q4 2019, an estimated $3.27M.
- Summit Securities Group first reported a position in Celgene Corp in Q2 2016 and held it in 4 quarters.
- Summit Securities Group's Celgene Corp position peaked at $3.27M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Summit Securities Group's 13F filing for Q4 2019, filed 13 Jan 2020.